Charles Pitman CFA
Stock Analyst at Barclays
(4.70)
# 762
Out of 4,703 analysts
373
Total ratings
68.5%
Success rate
16%
Average return
Main Sectors:
Stocks Rated by Charles Pitman CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: PPGN PolyPeptide Group AG | Downgraded: Hold | CHF 40.00 → CHF 44.31 | CHF 43.95 | +0.82% | 7 | Aug 14, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €140.00 | €135.85 | +3.05% | 21 | Aug 7, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 670.00 → CHF 680.00 | CHF 567.20 | +19.89% | 31 | Aug 7, 2026 | |
| LON: 0NZT UCB SA | Maintained: Hold | €300.00 → €260.00 | €212.15 | +22.55% | 132 | Aug 3, 2026 | |
| BIT: REC Recordati Industria Chimica e Farmaceutica S.p.A. | Reiterated: Hold | €48.00 → €50.00 | €51.90 | -3.66% | 16 | Jul 30, 2026 | |
| EPA: BIM bioMérieux S.A. | Maintained: Hold | €80.00 → €75.00 | €74.25 | +1.01% | 7 | Jul 28, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €220.00 → €210.00 | €190.30 | +10.35% | 18 | Jul 26, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €50.00 → €60.00 | €48.85 | +22.82% | 17 | Jul 14, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Hold | CHF 65.00 → CHF 70.00 | CHF 77.10 | -9.21% | 12 | Jun 9, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €270.00 | €237.20 | +13.83% | 22 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €13.50 → €12.50 | €9.89 | +26.34% | 17 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 75.00 | CHF 68.36 | +9.71% | 1 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $14.19 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $562.00 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | €105.00 → €60.00 | €75.36 | -20.38% | 3 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €700.00 → €850.00 | €905.60 | -6.14% | 26 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €120.00 → €125.00 | €164.70 | -24.10% | 30 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $674 → $755 | $1,033.15 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 | $7.80 | n/a | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $256.46 | n/a | 1 | Jan 13, 2022 |
PolyPeptide Group AG
Aug 14, 2026
Downgraded: Hold
Price Target: CHF 40.00 → CHF 44.31
Current: CHF 43.95
Upside: +0.82%
Merck KGaA
Aug 7, 2026
Reiterated: Hold
Price Target: €140.00
Current: €135.85
Upside: +3.05%
Lonza Group AG
Aug 7, 2026
Maintained: Buy
Price Target: CHF 670.00 → CHF 680.00
Current: CHF 567.20
Upside: +19.89%
UCB SA
Aug 3, 2026
Maintained: Hold
Price Target: €300.00 → €260.00
Current: €212.15
Upside: +22.55%
Recordati Industria Chimica e Farmaceutica S.p.A.
Jul 30, 2026
Reiterated: Hold
Price Target: €48.00 → €50.00
Current: €51.90
Upside: -3.66%
bioMérieux S.A.
Jul 28, 2026
Maintained: Hold
Price Target: €80.00 → €75.00
Current: €74.25
Upside: +1.01%
Sartorius Stedim Biotech S.A.
Jul 26, 2026
Maintained: Buy
Price Target: €220.00 → €210.00
Current: €190.30
Upside: +10.35%
Bayer Aktiengesellschaft
Jul 14, 2026
Maintained: Buy
Price Target: €50.00 → €60.00
Current: €48.85
Upside: +22.82%
Bachem Holding AG
Jun 9, 2026
Maintained: Hold
Price Target: CHF 65.00 → CHF 70.00
Current: CHF 77.10
Upside: -9.21%
Sartorius Aktiengesellschaft
Apr 23, 2026
Maintained: Buy
Price Target: €270.00
Current: €237.20
Upside: +13.83%
Apr 22, 2026
Maintained: Buy
Price Target: €13.50 → €12.50
Current: €9.89
Upside: +26.34%
Mar 11, 2026
Maintained: Hold
Price Target: CHF 75.00
Current: CHF 68.36
Upside: +9.71%
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $14.19
Upside: -
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $562.00
Upside: -
Jan 6, 2026
Downgraded: Sell
Price Target: €105.00 → €60.00
Current: €75.36
Upside: -20.38%
Oct 31, 2025
Maintained: Buy
Price Target: €700.00 → €850.00
Current: €905.60
Upside: -6.14%
Oct 24, 2025
Maintained: Hold
Price Target: €120.00 → €125.00
Current: €164.70
Upside: -24.10%
Apr 28, 2025
Maintained: Buy
Price Target: $674 → $755
Current: $1,033.15
Upside: n/a
Jan 4, 2024
Upgraded: Buy
Price Target: $21
Current: $7.80
Upside: n/a
Jan 13, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $256.46
Upside: n/a